Medical Review Policy

Review Process

Drug identification data on RXID.ai is sourced directly from federal APIs and does not undergo editorial modification. The data reflects what NIH, FDA, and NLM publish in their public databases.

Editorial content (articles, safety guides, FAQs) is reviewed for:

• Accuracy: Claims verified against current FDA data and medical literature
• Source verification: References confirmed and linked where appropriate
• Appropriate language: Content uses cautious language, avoids diagnostic certainty
• Currency: Information checked against the most recent federal data

Limitations

RXID.ai provides drug information, not medical advice. AI-based pill identification is probabilistic and should be confirmed by a pharmacist. Our review process ensures content accuracy but does not constitute medical guidance.